Scinovia

Point-and-Image to Know-the-Flow

Claim My Business View on StartEngine
Security Type
Non-Voting Equity
Categories
Technology
Min Investment
$228
Location
Raleigh, NC
Offering Date
January 07, 2022
Expected Close Date
May 29, 2022
Amount Raised
$93,519
Target Raise
$10K-$1M
No. Investors
61
Security Price
$2.85
Valuation
$89,300,000

Company Description

Scinovia’s mission is to produce state-of-the-art diagnostics to help doctors make more data-driven decisions during procedures to save more lives. Scinovia developed VUFLOW, the future of non-contact imaging diagnostics for blood flow during surgery.

Perks

StartEngine OWNERS Exclusive Click here to learn more

$498+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

$1,500+ Investment
$1,500+ Tier
Invest $1,500+ and receive 15% bonus shares

$5,000+ Investment
$5,000+ Tier
Invest $5,000+ and receive 20% bonus shares

$25,000+ Investment
$25,000+ Tier
Invest $25,000+ and receive 25% bonus shares

$50,000+ Investment
$50,000+ Tier
Invest $50,000+ and receive 30% bonus shares

$100,000+ Investment
$100,000+ Tier
Invest $100,000+ and receive 40% bonus shares

Key Deal Facts

Save more lives: A big challenge many surgeons face is knowing if procedures have optimal blood flow for quick recovery.
Disrupt a $500M market: Displace legacy contact probe* and dye* methods over past 60 years with VUFLOW, one of the first non-contact measurement device to visualize blood flow speeds in surface vessels during major surgeries.
Platform Technology: VUFLOW may be applicable to many types of surgeries. There are over 300M per year. Initial markets are heart bypass and organ transplants.
Sign up to vote

Security Description

Non-voting stock is stock that provides the shareholder very little or no vote on corporate matters.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments